New Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines for Advanced Non–Small Cell Lung Cancer: Comparison With Original RECIST and Impact on Assessment of Tumor Response to Targeted Therapy-Reference-Cited by-同舟云学术

New Response Evaluation Criteria in Solid Tumors (RECIST) Guidelines for Advanced Non–Small Cell Lung Cancer: Comparison With Original RECIST and Impact on Assessment of Tumor Response to Targeted Therapy

Published:2010-09 Issue:3 Volume:195 Page:W221-W228
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Nishino Mizuki,Jackman David M.,Hatabu Hiroto,Yeap Beow Y.,Cioffredi Leigh-Anne,Yap Jeffrey T.,Jänne Pasi A.,Johnson Bruce E.,Van den Abbeele Annick D.

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference19 articles.

1. New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

3. Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations

4. Individual patient data analysis to assess modifications to the RECIST criteria

5. A simulation study to evaluate the impact of the number of lesions measured on response assessment

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy;International Journal of Clinical Oncology;2024-03-22

2. Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial;Nature Communications;2024-02-19

3. Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors;American Journal of Cancer Research;2024

4. Predictive value of pre-operative prognostic nutritional index and systemic immune-inflammation index for efficacy and survival in patients with non-small cell lung cancer undergoing neoadjuvant chemotherapy;American Journal of Translational Research;2024

5. Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy;Journal of Thoracic Oncology;2023-12